Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Jefferies reiterates Buy on AbCellera stock, $21 target on VMS therapy

Jefferies reiterates Buy on AbCellera stock, $21 target on VMS therapy

Jefferies has reaffirmed its Buy rating for AbCellera Biologics (NASDAQ:ABCL) stock, maintaining a $21.00 price target. The company's stock is currently trading at $11.40, far below the analyst's target range of $14 to $30. Despite this, AbCellera has delivered an impressive 236% return year-to-date.

While the company is seen as potentially overvalued at its current valuation, three analysts have recently revised their earnings estimates upward. Jefferies highlights ABCL635 as a nonhormonal VMS therapy with strong potential for pivotal development and franchise value creation. For upcoming data, efficacy is expected to be assessed through the week 12 single-dose washout, which will inform dose selection rather than testing sustained benefit.

The positive outlook includes an encouraging execution framework with an existing formulation supporting one monthly injection. Other commercial opportunities include telehealth, direct-to-consumer sales, oncology-associated VMS, and quarterly payments. In its latest financial report, AbCellera showed a revenue increase to $10.6 million, surpassing Wall Street's forecast of $6.21 million, marking a 71.18% beat.

The company also reported a narrower net loss of $41.0 million, or $0.13 per share, compared to the expected $0.17 loss.

StoneX raised its price target for AbCellera to $15 from $11, maintaining a Buy rating. Meanwhile, AbCellera's lead antibody program, ABCL635, has shown promising late-stage-ready data. The company plans to begin late-stage development of ABCL635 in 2027. With cash and marketable securities exceeding $790 million and total available liquidity over $890 million, AbCellera is making significant strides in clinical development.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Other reports of this story

Every outlet that reported this, and when →

Read the original at investing.com →

More in Finance & Markets

Beyond the Asphalt: how Jetour’s High-Octane Lagos convoy brought clean water and hope to Iwerekun Orile

On Saturday, September 19, 2026, the roar of modern horsepower met the rhythm of drumming and celebration in Iwerekun Orile, Ibeju Lekki.

  • Jetour Nigeria showcased fleet of high-performance vehicles for 2026 Africa Expedition.
  • Final stop was Roman Catholic Mission Primary School in Iwerekun Orile.
  • Solar-powered borehole commissioned, providing clean water to community.

More from Monday 16 November →